Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark Rodacker"'
Autor:
Patricia L. Watkins, Mark Rodacker, Michael Laszewski, Tarek A. Dufan, Nadim Koleilat, John M. Watkins
Publikováno v:
Community Oncology. 10:197-201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7a4007780d1963b27074603ed6a8147
https://doi.org/10.12788/j.cmonc.0044
https://doi.org/10.12788/j.cmonc.0044
Autor:
John M. Watkins, James Kyle Russo, Nadim Koleilat, Michael Laszewski, Tarek A. Dufan, Patricia L. Watkins, Mark Rodacker
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 33:383.e1-383.e7
An involved surgical margin at prostatectomy has long been associated with elevated risk of prostate cancer recurrence; however, not all patients with an involved margin will relapse, and thus details of the involved margin may provide an opportunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e27bf36a5c776c5c06543d590a25eb0
https://doi.org/10.1016/j.urolonc.2015.05.022
https://doi.org/10.1016/j.urolonc.2015.05.022
Autor:
Mark Rodacker, Patricia L. Watkins, Michael Laszewski, James Kyle Russo, Nadim Koleilat, John M. Watkins, Tarek A. Dufan
Publikováno v:
Journal of Clinical Oncology. 33:131-131
131 Background: An involved surgical margin at prostatectomy has long been associated with elevated risk of prostate cancer recurrence; however, not all patients with an involved margin will relapse, and thus details of the involved margin may provid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1bc63c1f7b9eb11b8d4c9d8715a272
https://doi.org/10.1200/jco.2015.33.7_suppl.131
https://doi.org/10.1200/jco.2015.33.7_suppl.131
Publikováno v:
Journal of Clinical Oncology. 33:105-105
105 Background: Though an involved margin at prostatectomy has been associated with elevated rates of PSA relapse, there has been an absence of consensus regarding the risk of relapse specific to the site(s) of margin involvement. Specifically, the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::400f790427b45405484a3c89a500db4a
https://doi.org/10.1200/jco.2015.33.7_suppl.105
https://doi.org/10.1200/jco.2015.33.7_suppl.105
Publikováno v:
Endocrine pathology. 11(2)
Prohormone convertase (PC) 1/3 and PC2 are neuroendocrine-specific enzymes that convert prohormones to active hormones. To learn more about the role of these PCs in normal and neoplastic islet cells, we analyzed a series of pancreatic endocrine tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54ca2c7270ac96f8f426cb3e2c2ced5
https://pubmed.ncbi.nlm.nih.gov/12114824
https://pubmed.ncbi.nlm.nih.gov/12114824
Autor:
Patricia L. Watkins, Nadim Koleilat, John M. Watkins, Tarek A. Dufan, Michael Laszewski, Mark Rodacker
Publikováno v:
Journal of Clinical Oncology. 32:215-215
215 Background: EPE is an established risk factor for PSA failure following RP; however, often this is identified in the context of other high-risk feature(s). The objective of the current investigation study is to describe the PSA relapse rate for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::854db87b9da9e4746604dd532e897506
https://doi.org/10.1200/jco.2014.32.4_suppl.215
https://doi.org/10.1200/jco.2014.32.4_suppl.215